Clearmind Medicine Ownership | Who Owns Clearmind Medicine?


OverviewChart

Clearmind Medicine Ownership Summary


Clearmind Medicine is owned by 3.87% institutional investors, 4.46% insiders, and 91.67% retail investors. AdvisorShares Psychedelics ETF is the top mutual fund, with 0.10% of its assets in Clearmind Medicine shares.

CMND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockClearmind Medicine3.87%4.46%91.67%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20264100.00%44,962577.44%31186.20%4100.00%--
Dec 31, 20252-6,637---2---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
AdvisorShares Psychedelics ETF10.27K0.10%165.00

CMND Ownership FAQ


Who Owns Clearmind Medicine?

Clearmind Medicine shareholders are primarily institutional investors at 3.87%, followed by 4.46% insiders and 91.67% retail investors. The average institutional ownership in Clearmind Medicine's industry, Biotech Stocks , is 35.75%, which Clearmind Medicine falls below.

Does Blackrock own Clearmind Medicine?

BlackRock is not among the top 10 institutional shareholders of Clearmind Medicine.

Who is the top mutual fund holder of Clearmind Medicine shares?

AdvisorShares Psychedelics ETF is the top mutual fund holder of Clearmind Medicine shares, with 0.10% of its total shares outstanding invested in 10.27K Clearmind Medicine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools